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1. Introduction 
The epidemic of obesity is known to contribute annually to 2.6 million deaths worldwide. 
[1] Excessive adiposity is the primary etiology of major metabolic diseases and related 
mortality. These deaths are attributed mainly to the comorbidities associated with obesity, 
including hypertension (HTN), cardiovascular disease (CVD), and diabetes mellitus (DM). 
The global escalation of childhood obesity is a matter of grave concern. Recent data have 
demonstrated a nearly fourfold rise in the prevalence of childhood obesity, making the 
pediatric age group the fastest growing subpopulation of obese individuals in this country. 
[1] Corresponding data examining global obesity trends demonstrate similar patterns 
worldwide with rates of overweight—defined as having a body mass index (BMI) greater 
that 25 kg/m2—occurring in 40% of men and 30% of women and rates of obesity (BMI≥30 
kg/m2) at approximately 25%. [2] This condition can have far-reaching consequences on the 
physical and mental health of the young obese patients with many of these chronic diseases 
surging in childhood rather than adulthood.  
The normal BMI values used for defining overweight and obesity in adults cannot be 
extrapolated to the pediatric population as BMI is known to change with age and gender 
during childhood and adolescence. Center for Disease Control (CDC) BMI-for-age growth 
charts for girls and boys provide standard translation of a BMI number into a percentile 
with age and gender specific normograms. [3] Children with BMI equal to or exceeding the 
age-gender-specific 95th percentile are defined obese. Those with BMI equal to or exceeding 
the 85th but are below 95th percentiles are defined overweight. [4] 
2. Risk factors 
An inter-relationship of genetics and the environment is central to the regulation of energy 
balance, and thus body weight. Hence risk factors of the pandemic of obesity can be 
stratified on the basis of genetic and environmental sources.  
Genetic influence of obesity is related to two primary processes: (1) susceptibility to 
overeating despite normal energy requirements, and (2) presence of a normal drive to eat 
despite low energy requirements. Appetite and the drive to eat may be impacted by 
several genetically programmed metabolic pathways, and this is demonstrated in the 
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specific but rare syndromes such as Prader–Willi and Bardet–Biedl. [5] Obesity caused by 
single-gene mutations has been well documented in mice and other rodents but is 
relatively rare and ill-defined in humans. [6] These include the agouti, leptin, and leptin 
receptor gene mutations. These mutations produce phenotypes of severe hyperphagia, 
obesity, DM, defective thermogenesis, and infertility. The polygenic mouse models of 
obesity more closely resemble the human obesity phenotypes than single gene models 
and have mutations that influence obesity, plasma cholesterol levels, body fat 
distribution, and propensity toward development of obesity on a high-fat diet. [4]  
The impact of the environment on the regulation of energy balance, and thus body weight is 
paramount. The changes in the macronutrient content of the diet (i.e., carbohydrate, protein 
and fat), energy density, sugar-sweetened beverages, and portion size have been associated 
with the soaring trend of obesity over the last couple of decades. In addition, the global 
trend of increasing technology, automation, motorized transportation and sedentary 
occupations contributes to a lifestyle that requires minimal physical activity. While once 
essential for survival, regular physical activity is optional in our modern, low energy-
demanding environment, thereby making its contribution to the escalation of the pandemic. 
Poor socioeconomic status with less consumption of more expensive fruits and vegetables 
and suboptimal cognitive stimulation at home mediate development of obesity in children. 
[7-9] The dietary habits of the parents significantly modify child food preferences and the 
degree of parental adiposity is a relatively direct measure of the child’s dietary preferences. 
[10-12]  
3. Pathophysiology 
A breakdown in the complex interplay of the central nervous system, the gastrointestinal 
system and the adipose tissue of the body culminates in obesity. The central nervous system 
provides the feedback control system for integration of energy expenditure and for 
digestion, absorption, transport, and storage of nutrients and mobilization and use of fuels. 
Signals regarding alterations in fuel usage are tightly regulated and come primarily from 
adipocytes and from the gastrointestinal tract. This interaction of the different systems is 
responsible for the weight and fat balance of the human body.  
Adipose tissue is now known to play a significant role in metabolic and immune 
function, possibly through the production of pro-inflammatory cytokines and other 
hormones secreted by adipocytes. [13-14] In the past decade, pro-inflammatory 
adipocytokines, including TNF-α, IL-6, and leptin, resistin, and many others, have 
received tremendous attention for their potential role in fuel metabolism, glucose 
homeostasis, insulin resistance, and perhaps atherosclerosis. [13-15] In contrast to the 
proinflammatory hormones, adiponectin, a 244-amino-acid peptide solely produced and 
secreted by adipose tissue, has been reported to improve insulin sensitivity and indeed 
could prevent diabetes mellitus and atherosclerosis. [16] Leptin, also produced by the 
adipocytes, circulates at levels proportionate to levels of body fat. It binds to receptors in 
the hypothalamus, activating signals to inhibit food intake and increase energy 
expenditure. In addition, leptin affects other hormones, both anorectic and orexigenic. 
[17-18]  
Previous research has implicated gut hormones or incretins in appetite regulation, 
gastrointestinal motility, satiety, and changes in glucose, and in this regard may possibly 
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play a role in the occurrence of obesity. [19] In the foregut, ghrelin, produced in the stomach 
and duodenum, increases before meals and decreases after meals. [20] Ghrelin is elevated in 
the setting of obesity and increased after diet-induced weight loss, suggesting a role in the 
compensatory changes in appetite and energy expenditure that make maintenance of diet-
induced weight loss difficult. [21] In the hind-gut, where the suppression of gastrointestinal 
motility is modulated by hormones, such as peptide YY (PYY), neurotensin, glucagon-like 
peptide −1 (GLP-1), and oxyntomodulin, perturbations in hormone release have been 
demonstrated with weight loss secondary to Roux-en-Y gastric bypass. Peptide YY is a 
hormone released after meals whose function is to reduce appetite. [22] Its postprandial 
levels have been found to remain markedly elevated after bariatric surgery. [23] Better 
understanding of the interactions of the gut hormones on appetite and fuel metabolism will 
hopefully provide important information on the development of future obesity management 
strategies. 
4. Co-morbidities related to obesity 
Obesity in children and adolescents appears to be identical to obesity in adults, in both 
pathophysiology and consequences of obesity-related co-morbidities. These can be 
categorized broadly into medical and psychosocial. The medical consequences can result in 
metabolic effects, involving the cardiovascular, endocrine, gastrointestinal and renal 
systems, and mechanical effects involving the pulmonary, skeletal and central nervous 
systems.  
 
 
 
Fig. 1. Categories of co-morbidities 
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4.1 Metabolic consequences  
4.1.1 Endocrine system  
4.1.1.1 Insulin resistance 
Obesity has a negative impact on multiple associated alterations in the glucose/insulin axis 
and on lipid metabolism. In particular, obese adults demonstrate reduced glucose disposal, 
primarily at the level of skeletal muscle (peripheral insulin resistance) [24] as well as 
impairment in insulin action on non-esterified fatty acid oxidation, [25] leading to insulin 
resistance and abnormal lipolysis. Yet it is unclear when these abnormalities occur in the 
setting of acute versus chronic obesity. Polonsky and coworkers [26] found that insulin 
secretory rates were significantly higher in the obese group when compared with the 
normal weight group. Furthermore, there was no difference in insulin clearance or hepatic 
insulin extraction between the groups. There was a diminished hepatic insulin extraction 
noted in a subset of the obese group that demonstrated a greater degree of 
hyperinsulinemia. To characterize this further, Monti and coworkers [27] examined obese 
children with normo-insulinemia to characterize early metabolic derangement and found 
peripheral insulin resistance in the obese children when compared with normal weight 
children but no significant differences in non-esterified fatty acids response to insulin 
infusion. Le Stunff and coworkers [28] found that the earliest abnormality in glucose 
metabolism in obese children (those with short duration of obesity) was an abnormal insulin 
response to a meal stimuli and that maximal glucose uptake decreased with age and obesity 
duration. Thus, it appears that one of the earliest negative effects of obesity is the 
development of insulin resistance. 
4.1.1.2 Metabolic syndrome 
The metabolic syndrome complex is comprised of hyperglycemia, HTN, dyslipidemia and 
obesity where truncal fat and insulin resistance are thought to be the primary problems. 
There is no consensus in the definition of this syndrome in children and its role in future 
cardiovascular events can only be extrapolated from corresponding adult studies. Goodman 
et al. [29] identified four groups of risk factors in adolescents and inferred that obesity had 
maximal influence on cumulative cardio-metabolic risk. Each of the components of this 
syndrome complex is found to aggravate with increasing obesity independent of age, sex 
and pubertal status. [30] 
4.1.1.3 Type 2 diabetes mellitus 
The prevalence of pediatric DM has increased significantly over the last decade with 
significant variability based on race and ethnicity. Obesity and DM have been tightly 
linked in both animal models and adult humans. Recently, data on increasing incidence 
and prevalence of DM in adolescents demonstrate that insulin resistance and increases in 
both total body fat and visceral fat play a role in DM development in adolescents, similar 
to that seen in adults. [31-32] Obesity is associated with increased TNF-α levels which 
lead to increased release of free fatty acids in adipocytes, blockade of the synthesis of 
adiponectin and activation of the insulin receptor. [33] Moreover, IL-6, released mainly 
by macrophages and adipocytes, influences glucose tolerance through antagonizing the 
secretion of adiponectin and by enhancing gluconeogenesis, glycogenolysis and 
inhibiting glycogenesis. [34] There are numerous other adipokines like resistin, adipsin 
and others which are believed to be the missing link between obesity and target tissue 
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resistance to insulin resulting in Type DM. [35-37] With early onset of obesity, the 
population is believed to be more susceptible to the disease and its inadvertent 
complications. 
4.1.1.4 Gynecological disorders 
4.1.1.4.1 Polycystic ovarian syndrome (PCOS) 
Polycystic ovarian disease is one of the most common endocrine abnormalities and 
typically begins in adolescence. It is often accompanied by hyperandrogenism and 
hyperinsulinemia. Although the exact mechanism for this relationship is unclear, it is 
postulated that high circulating levels of insulin play a role in ovarian cyst development 
due to the anabolic effect of insulin at the IGF receptors on the ovaries. Up to 30% of 
women with polycystic ovarian disease are overweight/obese. Obesity can worsen the 
picture of polycystic ovary syndrome (PCOS) by increasing insulin resistance, diabetes, 
and metabolic syndrome, thereby commencing a vicious cycle. This cycle may culminate 
in infertility . The prevalence of impaired glucose tolerance in obese young women with 
PCOS has been estimated to be as high as 30-40%, with an additional 5-10% having frank 
DM. [38] Yet, there remains debate in the literature about the nature of the relationship 
between obesity and PCOS.  
4.1.1.4.2 Menstrual abnormalities 
Body weight and body fat are considered to be significant physiological triggers of 
menarche. [39] Hence, obese girls often present with menarche before the age of 10 years. 
[40] Obesity can also lead to oligomenorrhea or amenorrhea at the other end of the 
spectrum, all leading to an increased risk of complicated pregnancies.  
4.1.2 Cardiovascular system  
4.1.2.1 Hypertension 
Multiple studies showed childhood obesity to be a major determinant of the 
cardiovascular risk factors in adulthood. [41-42] In addition to overall increased adiposity, 
truncal obesity is associated with increased atherothrombotic events and increased 
inflammatory markers. [43-44] Hypertension, especially systolic, in children and 
adolescents is closely associated with adiposity. [45-46] Intima media thickness (IMT), a 
noninvasive marker for early atherosclerotic changes, was found to be significantly 
increased in the obese children as compared with non-obese children of similar age, sex, 
and pubertal stage. [47-50] Reinehr et al. further demonstrated a significant association 
between these atherogenic changes and CVD risk factors, HTN, impaired glucose 
metabolism, and chronic inflammation. [51]  
4.1.2.2 Left ventricular hypertrophy and coronary artery disease 
The onset of left ventricular hypertrophy (LVH) was believed to date back to the adolescent 
years and developed into a formidable CVD risk factor by young adulthood in this sub-
population. [52] Maggio et al. showed the onset of this relationship between obesity and 
LVH in the pre-pubertal age group and proposed the initiation of prevention and treatment 
of obesity to prevent end-stage organ damage. [53] A prospective follow-up over 57 years of 
the landmark Harvard Growth Study of 1922-1935 revealed that being overweight in 
adolescence was associated with a greater than two-fold increase in the relative risk of  
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coronary artery disease mortality, independent of adult weight.[54] Hence, these patients 
with an advanced vascular age may need intensive management, including 
pharmacotherapy for risk factor modification, with the final goal of halting the progression 
of atherosclerosis and altering the lifetime risk of excess morbidity and mortality.  
4.1.3 Gastrointestinal system 
4.1.3.1 Non-alcoholic steatohepatitis (NASH) 
The incidence of hepatic steatosis is 38% in obese children. The underlying cause is 
unknown, but the condition is associated with DM, obesity, rapid weight loss, and 
hyperlipidemia—all of which are characterized by impaired fat metabolism. Non-alcoholic 
fatty liver disease (NAFLD) is the primary hepatic complication of obesity and insulin 
resistance, and may be considered the early hepatic manifestation of metabolic syndrome. 
[55] One study demonstrated that non-alcoholic fatty liver disease is associated with insulin 
resistance even in patients with normal glucose tolerance. In the pediatric population, 
results demonstrate increased adipose tissue lipolytic activity  with resulting increased rates 
of fatty acid release into plasma throughout the day. This continual excess in fatty acid flux 
supports the hypothesis that adipose insulin resistance is implicated in the pathogenesis of 
steatosis and contributes to the metabolic complications associated with NASH. [56] The fats 
accumulate largely in adipose tissue and, inappropriately, in muscle and liver. The sequence 
of events leading to the ectopic accumulation of triglycerides which cause development of 
insulin resistance has been referred to as the “overflow hypothesis”. [57] The severe cases of 
this disease are notorious to progress to hepatic fibrosis and cirrhosis. 
4.1.3.2 Gallstones 
The dyslipidemia induced by obesity is responsible for increased biliary excretion of 
cholesterol, thereby increasing the likelihood of gallstone formation. Unlike the majority of 
children, this subgroup of the population complains of gallstones without any underlying 
diseases like hemolytic disorders. Obesity is incriminated to cause 8% to 33% of gallstones in 
children, with insulin resistance and metabolic syndrome being other potential risk 
factors.[58-59] 
4.1.4 Renal system 
Obesity plays a major role in the development of chronic kidney disease (CKD). It 
predisposes the individual to diabetic nephropathy, hypertensive nephrosclerosis, focal and 
segmental glomerular sclerosis and urolithiasis. Even in the absence of other comorbidities, 
obesity has been found to cause structural changes such as glomerulomegaly and 
glomerular basement membrane (GBM) thickening resulting in obesity-related 
nephropathy. [60-61] The physiological modification in renal hemodynamics in the setting 
of obesity is comprised of hyperfiltration associated with hyperperfusion, which together 
play a role in renal injury. An increased glomerular filtration rate (GFR) was observed in 
overweight compared with lean subjects, being significantly positively related to BMI [62-
63] and insulin resistance. [64] However, pathologic changes within the nephron can be seen 
before overt proteinuria and renal disease. A recent study conducted in our institution 
revealed that bariatric surgery induced weight loss is associated with an improvement in the 
overall long term renal function in the morbidly obese adult. [65] Such data are lacking for 
the pediatric population. Recent European studies concluded that renal impairment may not 
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be an early manifestation of adiposity in childhood but may contribute to the development 
of the disease in the long term. [66]  
4.2 Mechanical consequences 
4.2.1 Pulmonary system 
4.2.1.1 Obstructive sleep apnea 
Although there is limited data on obstructive sleep apnea (OSA) in children, the published 
estimate of prevalence is 7% in obese children. Obese children are six times more likely than 
lean, age-matched children to have OSA. This condition is known to cause daytime 
somnolence and neurocognitive deficits like concentration and memory lapses secondary to 
poor quality of sleep. [67-68]  Sleep disturbance is linked to higher inflammatory biomarkers, 
such as CRP and IL-6. [69] Other hormone changes seen in OSA include a drop in leptin, an 
increase in ghrelin, increased insulin levels, and a decrease in insulin sensitivity. The etiology 
for these changes is unclear but felt to be related to the intermittent hypoxemia that may 
potentiate the inflammatory cascade which triggers systemic inflammation. [70-71] 
4.2.1.2 Bronchial hyperactivity and exacerbation of asthma 
Obesity is demonstrated to be significantly related to current asthma among children and 
adolescents with the association being stronger in non-atopic children than in atopic 
children. [72-73] The state of systemic inflammation, induced by adiposity, is hypothesized 
to result in this morbid condition. Overweight & obese children show a decreased response 
to inhaled steroids in the setting of asthma. [74] Childhood and adolescent adiposity is 
reported to be associated with significantly increased risk of asthma in the long term as well, 
thereby increasing the dependence on chronic medication. [75] Inability to exercise leads to 
the progression of obesity and the cycle continues.  
4.2.2 Musculoskeletal system  
Childhood obesity has been linked to increase frequency and severity of orthopedic 
problems in children. It appears that the orthopedic issues occur due to increased stress and 
strain on bone and cartilage that was not designed to carry excess weight. The more 
common orthopedic problems include bowing of the tibia and femurs that result in 
overgrowth of the medial aspect of the proximal tibial metaphysis or Blount syndrome and 
slipped capital femoral epiphysis due to increased weight on the growth plate of the hip. 
[76] Obesity during the growth spurt may increase the likelihood of fractures during falls as 
bone development does not adequately cope with excess weight.  This weight/bone mass 
imbalance also places high levels of stress on growing bones and joints that may result in 
joint damage and may contribute to osteoarthritis in later years. [77] The occurrence of more 
severe fractures and bone disorders lead to the increased requirement of complex surgeries 
and joint replacements, especially in the setting of pediatric trauma, thus amplifying the 
physical and financial load of the disease in this population. [78] 
4.2.3 Central nervous system 
Corbett et al reported increased incidence of idiopathic intracranial hypertension at a 
relatively young age of less than 20 years in 90% of patients who had childhood obesity. [79] 
Moreover, about 30%-50% of children with pseudotumor cerebri are obese and probably this 
subgroup accounts for the majority of cases that are not associated with infection or 
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medication. [80] It is thought that the increased intra-abdominal pressure due to obesity 
causes rise in intra-thoracic pressure which is transmitted to the head as increased resistance 
to venous return from the brain. [81] 
4.3 Psychosocial consequences 
Childhood obesity represents a dynamic process, in which behavior, cognition and emotional 
regulation interact mutually with each other. The interconnection between obesity and 
psychological problems seems to be cyclical, in that clinically meaningful psychological 
distress might precipitate weight gain and obesity may lead to further psychosocial problems. 
[82] Depression in adulthood has been found to be related to obesity in adolescence. [83] 
Females appear to have a stronger association than males. These patients are found to have 
obsessive concern due to social stigma about body image, low esteem and poor self-perception 
of physical appearance. The expectation of rejection leads to further progression of depression. 
Overweight adolescents frequently reported reduced health-related quality of life in physical, 
emotional and social aspects. [84-86] These factors tend to have a negative influence on these 
individuals. A vicious cycle ensues and some of these obese adolescents may consequently 
have less education, lower incomes and higher poverty rates. [87-88] 
5. Conclusion 
Despite the lack of full understanding of the pathophysiology of obesity, it is clear that there 
are consistent findings of insulin resistance and inflammation seen in both obese adults and 
children. These metabolic abnormalities play a role in the development of obesity-related 
comorbidities that are manifested early in the disease process.  Inflammation in the adipose 
tissue is the result of increased oxidative stress, possibly secondary to hypoxia. Hypoxia is 
precipitated by the overgrowth of adipose tissue during obesity. Adipose tissue is 
responsible for the production of a significant proportion of systemic interleukin-6 (IL-6) 
which may induce a degree of systemic inflammation in this population. Along with this, it 
is also believed to activate CD8+ T cells which promote the recruitment and activation of 
macrophages in the tissue. [89] The inflammatory markers secreted by the cells and oxygen 
free radicals resulting from oxidative stress increase vascular endothelial permeability and 
cause endothelial dysfunction. [90-91] These abnormalities lay the foundation for all the 
derangements associated with obesity. Unfortunately, there is very limited data on the 
progress of the various comorbidities from childhood and adolescence to their culmination 
in adulthood. A study reported that 43% of obese children persisted to be obese adults and 
another 29% were overweight as adults. [92] Early onset obesity is a risk factor for 
significant morbidity and mortality later in life, where the rates of DM, CAD, 
atherosclerosis, metabolic syndrome are increased.  A heightened degree of suspicion is 
warranted when confronted with adult and pediatric obese patients to avoid 
underdiagnosing of the various diseases. Given the negative short- and long-term impact of 
obesity on children, careful attention should be paid to the unique health issues of this “at-
risk” population with both prevention and aggressive early intervention strategies. 
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